Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

6.64
BATS BZX Real-Time Price
As of 12:23pm ET
 +0.21 / +3.27%
Today’s Change
5.70
Today|||52-Week Range
16.30
-7.26%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$260.2M

Company Description

Advaxis, Inc. is a clinical-stage biotechnology company, which intends to develop immunotherapies for cancer and infectious diseases. The company's platform technology is designed to generate a comprehensive immune response by serving as its own adjuvant, directing antigen presentation, increasing tumor infiltrating killer T-cells, and decreasing Tregs/MDSCs in the tumor. Advaxis was founded on June 5, 1987 and is headquartered in Princeton, NJ.

Contact Information

Advaxis, Inc.
305 College Road East
Princeton New Jersey 08540
P:(609) 452-9813
Investor Relations:

Employees

Shareholders

Other institutional32.66%
Mutual fund holders24.02%
Individual stakeholders20.60%

Top Executives

Daniel J. O'ConnorPresident, Chief Executive Officer & Director
Christopher M. DukeChief Operating Officer & Senior Vice President
Sara BonsteinChief Financial Officer & Senior Vice President
Robert G. PetitChief Scientific Officer & Executive VP
Mayo PujolsSenior Vice President-Technical Operations